141 related articles for article (PubMed ID: 17679408)
21. [Results of Russian multicenter trial of immunogenicity, reactogenicity and safety of new combination vaccine against hepatitis A and B (Twinrix)].
Tatochenko VK; Il'ina NI; Romanenko VV; Alikova OA; Fassakhov RS; Miasnikova TN; Patlusova VV; Zima IuIu; Reshetnikova ID; Frolova GS; Smolenov IV
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):30-5. PubMed ID: 17163135
[TBL] [Abstract][Full Text] [Related]
22. Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults.
Nyamathi A; Liu Y; Marfisee M; Shoptaw S; Gregerson P; Saab S; Leake B; Tyler D; Gelberg L
Nurs Res; 2009; 58(1):13-22. PubMed ID: 19092551
[TBL] [Abstract][Full Text] [Related]
23. Completion and subject loss within an intensive hepatitis vaccination intervention among homeless adults: the role of risk factors, demographics, and psychosocial variables.
Stein JA; Nyamathi AM
Health Psychol; 2010 May; 29(3):317-23. PubMed ID: 20496986
[TBL] [Abstract][Full Text] [Related]
24. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.
Cardell K; Akerlind B; Sällberg M; Frydén A
J Infect Dis; 2008 Aug; 198(3):299-304. PubMed ID: 18544037
[TBL] [Abstract][Full Text] [Related]
25. Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.
De Schryver A; Verstrepen K; Vandersmissen L; Vandermeeren N; Vernaillen I; Vranckx R; Van Damme P; van Sprundel M
J Viral Hepat; 2011 Apr; 18(4):e5-10. PubMed ID: 20735800
[TBL] [Abstract][Full Text] [Related]
26. The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.
Chen Y; Gu H; Cheng S; Shen L; Cui F; Wang F; Yao J; Xia S; Lv H; Liang X
Hum Vaccin Immunother; 2013 Apr; 9(4):898-902. PubMed ID: 23295964
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
29. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years.
Marshall H; Nolan T; Díez Domingo J; Rombo L; Sokal EM; Marès J; Casanovas JM; Kuriyakose S; Leyssen M; Jacquet JM
Vaccine; 2010 Jun; 28(27):4411-5. PubMed ID: 20434544
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of Twinrix in older adults: a critical analysis.
Stoffel M; Lievens M; Dieussaert I; Martin I; André F
Expert Rev Vaccines; 2003 Feb; 2(1):9-14. PubMed ID: 12901592
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of completing an accelerated vaccine series for homeless adults.
Nyamathi AM; Sinha K; Saab S; Marfisee M; Greengold B; Leake B; Tyler D
J Viral Hepat; 2009 Sep; 16(9):666-73. PubMed ID: 19245384
[TBL] [Abstract][Full Text] [Related]
33. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
35. Prevalence, risk factors and hepatitis B immunization: helping fill the gap on hepatitis B epidemiology among homeless people, Goiânia, Central Brazil.
Carvalho PMRDS; Matos MA; Martins RMB; Pinheiro RS; Caetano KAA; Souza MM; Carneiro MADS; Teles SA
Cad Saude Publica; 2017 Aug; 33(7):e00109216. PubMed ID: 28792993
[TBL] [Abstract][Full Text] [Related]
36. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
37. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
[TBL] [Abstract][Full Text] [Related]
38. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
39. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines.
Ramonet M; da Silveira TR; Lisker-Melman M; Rüttimann R; Pernambuco E; Cervantes Y; Cañero-Velasco MC; Falleiros-Carvalho LE; Azevedo T; Targa-Ferreira C; Clemens SA
Arch Med Res; 2002; 33(1):67-73. PubMed ID: 11825634
[TBL] [Abstract][Full Text] [Related]
40. Ethnic differences in the correlates of mental distress among homeless women.
Austin EL; Andersen R; Gelberg L
Womens Health Issues; 2008; 18(1):26-34. PubMed ID: 18069002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
